<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//FR">
<HTML>
<HEAD>
 <LINK HRef="../CSS/ggrcm.css"   Rel="stylesheet" Type="text/css">
 <META name="description" content="M&eacute;dicaments &agrave; base de parecoxib natrium">
 <META name="keywords" content="Centre Belge d'Information Pharmacoth&eacute;rapeutique; parecoxib natrium">
 <TITLE>M&eacute;dicaments &agrave; base de Parac&eacute;tamol</TITLE>
</HEAD>

<BODY bgcolor="#FFFFFF" LeftMargin="0" RightMargin="0" TopMargin="0" BottomMargin="0" MarginWidth="0" MarginHeight="0">
  <A Name="TopOfPage"></A>

  <TABLE Width="100%" Border="0" CellPadding="0" CellSpacing="0">
   <TR> 
    <TD Width="10">&nbsp;</TD>
    <TD Width="30%"><A HRef="../HeaderTxt/LeCBIP.htm">Le C.B.I.P.</A></TD>
    <TD Width="30%"><A HRef="../HeaderTxt/NousContacter.htm">Nous contacter</A></TD>
    <TD Width="30%"><A HRef="../HeaderTxt/Liens.htm">Sites Int&eacute;ressantes</A></TD>
   </TR> 
   <TR> 
    <TD Width="10">&nbsp;</TD>
    <TD Width="30%" Class="footer">Bon &agrave; savoir</TD>
    <TD Width="30%"><A HRef="../Index.htm"><B>Le R&eacute;pertoire</B></A></TD>
    <TD Width="30%" Class="footer">Folia</TD>
   </TR> 
   <TR> 
    <TD ColSpan="4"><HR></TD>
   </TR> 
  </TABLE> 


  <TABLE Width="100%" Border="0" CellPadding="0" CellSpacing="10">
   <TR>
    <TD>
     <H1>M&eacute;dicaments &agrave; base de <FONT Color="red">Parac&eacute;tamol</FONT></H1>
     <TABLE Width="100%" Border="0" CellPadding="5" CellSpacing="10">
      <TR>
       <TD vAlign="top" Width="33%">
         <P><FONT CLASS="Text">4. Syst&egrave;me respiratoire<BR>4.2. Antitussifs, mucolytiques et expectorants<BR>4.2.3. Associations<BR></FONT><A Class="HYR_INMP"  HREF="../MPG/MPG_DBC.htm">4.2.3.1. *</A><BR>
         <A Class="MP_INMP"  HREF="../MPG/MPG_DBC.htm#MP_00735">-Toplexil</A> [<FONT class="footer">parac&eacute;tamol</FONT>]<BR>
         <P><FONT CLASS="Text">8. Douleur et fi&egrave;vre<BR>8.2. Analg&eacute;siques - Antipyr&eacute;tiques<BR>8.2.1. Parac&eacute;tamol<BR></FONT><A Class="HYR_INMP"  HREF="../MPG/MPG_HBA.htm">8.2.1.1. *</A><BR>
         <A Class="MP_INMP"  HREF="../MPG/MPG_HBA.htm#MP_00806">-Algostase Mono</A> [<FONT class="footer">parac&eacute;tamol</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_HBA.htm#MP_00808">-Dafalgan</A> [<FONT class="footer">parac&eacute;tamol</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_HBA.htm#MP_00810">-Dolol-Instant</A> [<FONT class="footer">parac&eacute;tamol</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_HBA.htm#MP_00811">-Dolprone</A> [<FONT class="footer">parac&eacute;tamol</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_HBA.htm#MP_00812">-Lemsip</A> [<FONT class="footer">parac&eacute;tamol</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_HBA.htm#MP_00813">-Panadol</A> [<FONT class="footer">parac&eacute;tamol</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_HBA.htm#MP_00814">-Paracetamol EG</A> [<FONT class="footer">parac&eacute;tamol</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_HBA.htm#MP_00816">-Perdolan</A> [<FONT class="footer">parac&eacute;tamol</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_HBA.htm#MP_00818">-Sanicopyrine</A> [<FONT class="footer">parac&eacute;tamol</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_HBA.htm#MP_00819">-Croix Blanche Mono</A> [<FONT class="footer">parac&eacute;tamol</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_HBA.htm#MP_02712">-Paracetamol Teva</A> [<FONT class="footer">parac&eacute;tamol</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_HBA.htm#MP_03353">-Pe-Tam</A> [<FONT class="footer">parac&eacute;tamol</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_HBA.htm#MP_04859">-Paracetamol Mylan</A> [<FONT class="footer">parac&eacute;tamol</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_HBA.htm#MP_05001">-Mobistix</A> [<FONT class="footer">parac&eacute;tamol</FONT>]<BR>
       </TD>
       <TD vAlign="top" Width="33%">
         <A Class="MP_INMP" HREF="../MPG/MPG_HBA.htm#MP_05084">-Paracetamol Fresenius Kabi</A> [<FONT class="footer">parac&eacute;tamol</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_HBA.htm#MP_05356">-Panadol</A> [<FONT class="footer">parac&eacute;tamol</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_HBA.htm#MP_05357">-Paracetamol Actavis</A> [<FONT class="footer">parac&eacute;tamol</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_HBA.htm#MP_05557">-Paracetamol Macopharma</A> [<FONT class="footer">parac&eacute;tamol</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_HBA.htm#MP_05682">-Paracetamol Sandoz</A> [<FONT class="footer">parac&eacute;tamol</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_HBA.htm#MP_05848">-Paraphar</A> [<FONT class="footer">parac&eacute;tamol</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_HBA.htm#MP_05905">-Paracetamol B. Braun</A> [<FONT class="footer">parac&eacute;tamol</FONT>]<BR>
         <P><FONT CLASS="Text">8. Douleur et fi&egrave;vre<BR>8.2. Analg&eacute;siques - Antipyr&eacute;tiques<BR>8.2.5. Associations<BR></FONT><A Class="HYR_INMP"  HREF="../MPG/MPG_HBE.htm">8.2.5.1. Parac&eacute;tamol + caf&eacute;ine</A><BR>
         <A Class="MP_INMP"  HREF="../MPG/MPG_HBE.htm#MP_00840">-Algostase</A> [<FONT class="footer">parac&eacute;tamol</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_HBE.htm#MP_00841">-Antigriphine</A> [<FONT class="footer">parac&eacute;tamol</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_HBE.htm#MP_00848">-Lonarid N</A> [<FONT class="footer">parac&eacute;tamol</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_HBE.htm#MP_00849">-Mann</A> [<FONT class="footer">parac&eacute;tamol</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_HBE.htm#MP_00853">-Panadol Plus</A> [<FONT class="footer">parac&eacute;tamol</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_HBE.htm#MP_00859">-Croix Blanche</A> [<FONT class="footer">parac&eacute;tamol</FONT>]<BR>
         <P><FONT CLASS="Text">8. Douleur et fi&egrave;vre<BR>8.2. Analg&eacute;siques - Antipyr&eacute;tiques<BR>8.2.5. Associations<BR></FONT><A Class="HYR_INMP"  HREF="../MPG/MPG_HBE.htm">8.2.5.4. Parac&eacute;tamol + acide ac&eacute;tylsalicylique + caf&eacute;ine</A><BR>
         <A Class="MP_INMP"  HREF="../MPG/MPG_HBE.htm#MP_00856">-Perdolan Compositum</A> [<FONT class="footer">parac&eacute;tamol</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_HBE.htm#MP_00858">-Troc</A> [<FONT class="footer">parac&eacute;tamol</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_HBE.htm#MP_05266">-Excedryn</A> [<FONT class="footer">parac&eacute;tamol</FONT>]<BR>
         <P><FONT CLASS="Text">8. Douleur et fi&egrave;vre<BR>8.2. Analg&eacute;siques - Antipyr&eacute;tiques<BR>8.2.5. Associations<BR></FONT><A Class="HYR_INMP"  HREF="../MPG/MPG_HBE.htm">8.2.5.5. Parac&eacute;tamol + acide ac&eacute;tylsalicylique + acide ascorbique</A><BR>
         <A Class="MP_INMP"  HREF="../MPG/MPG_HBE.htm#MP_00839">-Afebryl</A> [<FONT class="footer">parac&eacute;tamol</FONT>]<BR>
         <P><FONT CLASS="Text">8. Douleur et fi&egrave;vre<BR>8.3. Analg&eacute;siques morphiniques<BR>8.3.2. Associations<BR></FONT><A Class="HYR_INMP"  HREF="../MPG/MPG_HCB.htm">8.3.2.1. Parac&eacute;tamol 500 mg + cod&eacute;ine 30 mg</A><BR>
         <A Class="MP_INMP"  HREF="../MPG/MPG_HCB.htm#MP_00845">-Dafalgan Codeine</A> [<FONT class="footer">parac&eacute;tamol</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_HCB.htm#MP_00846">-ParacodMylan</A> [<FONT class="footer">parac&eacute;tamol</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_HCB.htm#MP_00852">-Panadol Codeine</A> [<FONT class="footer">parac&eacute;tamol</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_HCB.htm#MP_02854">-Algocod</A> [<FONT class="footer">parac&eacute;tamol</FONT>]<BR>
         <P><FONT CLASS="Text">8. Douleur et fi&egrave;vre<BR>8.3. Analg&eacute;siques morphiniques<BR>8.3.2. Associations<BR></FONT><A Class="HYR_INMP"  HREF="../MPG/MPG_HCB.htm">8.3.2.2. Tramadol + parac&eacute;tamol</A><BR>
         <A Class="MP_INMP"  HREF="../MPG/MPG_HCB.htm#MP_00981">-Zaldiar</A> [<FONT class="footer">parac&eacute;tamol</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_HCB.htm#MP_04949">-Pontalsic</A> [<FONT class="footer">parac&eacute;tamol</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_HCB.htm#MP_05613">-Tramadol / Paracetamol Teva</A> [<FONT class="footer">parac&eacute;tamol</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_HCB.htm#MP_05684">-Tramadol / Paracetamol EG</A> [<FONT class="footer">parac&eacute;tamol</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_HCB.htm#MP_05871">-Tramadol / Paracetamol Mylan</A> [<FONT class="footer">parac&eacute;tamol</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_HCB.htm#MP_05976">-Algotra</A> [<FONT class="footer">parac&eacute;tamol</FONT>]<BR>
         <P><FONT CLASS="Text">8. Douleur et fi&egrave;vre<BR>8.3. Analg&eacute;siques morphiniques<BR>8.3.2. Associations<BR></FONT><A Class="HYR_INMP"  HREF="../MPG/MPG_HCB.htm">8.3.2.3. Autres associations</A><BR>
         <A Class="MP_INMP"  HREF="../MPG/MPG_HCB.htm#MP_00850">-Nevrine Codeine</A> [<FONT class="footer">parac&eacute;tamol</FONT>]<BR>
         <P><FONT CLASS="Text">17. Oto-Rhino-Laryngologie<BR>17.3. Rhinite et sinusite<BR>17.3.1. M&eacute;dicaments &agrave; usage oral<BR>17.3.1.3. M&eacute;dicaments oraux divers en cas de rhinite<BR></FONT><A Class="HYR_INMP"  HREF="../MPG/MPG_QCAC.htm">17.3.1.3.1. *</A><BR>
         <A Class="MP_INMP"  HREF="../MPG/MPG_QCAC.htm#MP_00751">-Niocitran</A> [<FONT class="footer">parac&eacute;tamol</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_QCAC.htm#MP_00752">-Rhinofebryl</A> [<FONT class="footer">parac&eacute;tamol</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_QCAC.htm#MP_00753">-Sinutab</A> [<FONT class="footer">parac&eacute;tamol</FONT>]<BR>
       </TD>
      </TR>
     </TABLE>
<P Class="datum">
 <A Href="#TopOfPage">
 <IMG SRC="../Images/TopOfPage.gif" Width="18" Height="10" Border="0" onmouseover="return escape('Haut de page')"></A>&nbsp;
</P>

    </TD>
   </TR>
  </TABLE>
 <TABLE Width="100%" Border="0" CellPadding="0" CellSpacing="10">
  <TR>
   <TD Align="center">
    <HR WIDTH="90%" SIZE="1" COLOR="#008000" NOSHADE>
    <SPAN Class="footer">
 Centre Belge d 'Information Pharmacoth&eacute;rapeutique (C.B.I.P. asbl) <BR>
 c/o Heymans Instituut, De Pintelaan 185, 9000 Gent<BR>
 </SPAN>
 <A HRef="" Target="_top" Class="footer_link"><font color="#0000FF"></font></A> -
 <A HRef="mailto:redaction@cbip.be" Class="footer_link"><font color="#0000FF">redaction@cbip.be</font></A>
 - <A HRef="../Headertxt/Avertissement.htm" target="_blank" class="footer_link"><FONT Color="#0000FF">Avertissement / Disclaimer</FONT></A>
   </TD>
  </TR>
 </TABLE>

<script language="JavaScript" type="text/javascript" SRC="../JS/wz_tooltip.js"></script>
</BODY>
</HTML>
